We are making progress in the fight against Alzheimer’s disease. The human brain is complex, but prioritizing Alzheimer’s ...

a common brain disorder causing damage to human brain cells. Dementia in recent times has become very common as damage to ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

Researchers found that inhibiting the enzyme TYK2 may reduce the harmful accumulation of tau protein in Alzheimer’s disease, ...

"There is still much to do, but we are excited by these new findings that reshape our understanding of brain aging. Together with our clinical collaborators, we are committed to advancing this ...

Dementia and Alzheimer’s disease are a growing concern for future generations, and Michigan State University plans to use a ...

Several studies demonstrate its brain-boosting powers, including enhanced cognitive function, a reduced risk of dementia and ...

Exercise has been shown to improve brain health and reduce the risk of cognitive decline and dementia over the long-term ... and Martin Sliwinski, professor of human development and family studies.

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...

Researchers are uncovering deeper insights into how the human brain ages and what factors may be tied to ... along with other ...

However research suggests that almost half (45%) of dementia cases are linked to risk factors we have some control over. This means that we can reduce our risk of getting it by taking steps to protect ...